As NHS waiting lists grow, the need for operational gains intensifies. Hospitals need to be able to make faster diagnoses and deliver more efficient treatments to free up bed space and admit more patients. The issue is not simply about the NHS working harder, but working smarter, and this is where MedTech can help.

This podcast will delve into the ways in which MedTech can support hospitals as a whole, rather than just individual patients or clinicians. The panellists will also be discussing how MedTech companies can utilise this in selling their own products.

The NHS's target is to become the world’s first 'net zero’ national health service. Their ambitious plan shows that the greatest areas of opportunity are in the supply chain, estates and facilities, pharmaceuticals and medical devices, and travel.

What does this mean for the MedTech industry and what do you need to prepare for?

Michael Branagan-Harris is joined by John West and Emily Arbuthnot to discuss the mounting pressure on the NHS. The session covers everything from waiting lists to how to engage with healthcare professionals to expedite your journey into the NHS. 

This episode is also available on Youtube, simply search for Device Access to find our channel. 

This webinar featured an impressive group of panellists, including:
-Michael Branagan-Harris, CEO, Device Access
-James Lindley, Commercial Counselor, US Embassy London
-Jeff Dillon, UK Dept International Trade DIT
-Amit Kukreja, Vice President | Corporate Market Access & Reimbursement at Masimo
Former Vice President, Global Marketing, Reimbursement and Patient Access at Second Sight Medica. Products
-Dawn Smiles, Founder and Clinical Director at MedTec Consulting Ltd
-Michael Kujak, Former Chief Marketing Officer & SVP International Commercialization NxThera Inc
-John West, Director, Pellere Health

This episode is also available on Youtube, simply search for Device Access to find our page. 

Our panellists are:
Michael Branagan-Harris - CEO, Device Access UK
Mattias Kyhlstedt - CEO, Synergus
Professor Tom Clutton-Brock FRCP, FRCA, FFICM- Director, Medical Devices Testing and Evaluation Centre & Chair, NICE Interventional Procedures Advisory Committee
Dr Peter Walton - Managing Director, Dendrite Clinical Systems

Michael Branagan-Harris (CEO of Device Access) will be joined by Bruce Robinson, an expert in private hospital reimbursement. Bruce has worked for various private groups including BUPA, BMI Healthcare and Nuffield Health.